Neuro-Oncologist Dr. Samuel Singer Joins John Theurer Cancer Center

Fri, August 16, 2013

August 16, 2013 (Hackensack, NJ) – John Theurer Cancer Center at Hackensack University Medical Center, one of the nation’s top 50 U.S. News and World Report Best Hospitals for cancer, has expanded its Neurological Oncology Division with the addition of Neuro-Oncologist Samuel Singer, M.D.

“Dr. Singer will significantly enhance our mission to provide unparalleled clinical care and cutting-edge research to our patients,” said Samuel Goldlust, M.D., Co-Chief, Neurological Oncology Division – The Brain and Spine Institute, John Theurer Cancer Center. “His breadth and depth of knowledge of cancer’s impact on the nervous system has him poised to emerge as one of the nation’s leading neuro-oncologists and we are thrilled to have him join our first-in-class team.”

Prior to working at the John Theurer Cancer Center, Dr. Singer completed a fellowship in neuro-oncology at Memorial Sloan-Kettering Cancer Center and his residency in neurology at New York-Presbyterian Hospital/Weill Cornell Medical Center.

“Dr. Singer’s appointment demonstrates our continued commitment and expansion of services in neurological oncology,” said Andre Goy, M.D., M.S., Chairman and Director, and Chief of Lymphoma, John Theurer Cancer Center and Chief Science Officer and Director of Research and Innovation of Regional Cancer Care Associates.

Dr. Singer is a member of the American Academy of Neurology, the American Society of Clinical Oncology and the Society for Neuro-Oncology. He is widely published in peer-reviewed journals, including Neurosurgery, Neurology and the Journal of Neuro-Opthalmology.

“With Dr. Singer’s world-class training and depth of expertise, we continue to strengthen our patient offerings in the Neurological Oncology Division,” said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer, Professor, and Vice President of Cancer Services, John Theurer Cancer Center and President of Regional Cancer Care Associates. “Expanding our neuro-oncology team and research allows us to accelerate cancer discovery and improve patient outcomes and quality of life.”

John Theurer Cancer Center’s Neuro-Oncology Division comprises a specialized team of professionals who are dedicated to preventing, diagnosing, treating, and managing cancers of the brain and spinal cord. The team brings together experts in neurology, neurosurgery, medical oncology, radiation oncology, behavioral health, neuro-radiology, otolaryngology, pathology, and nursing.

About the John Theurer Cancer Center at Hackensack University Medical Center
John Theurer Cancer Center at Hackensack University Medical Center is among the nation’s top 50 U.S. News and World Report Best Hospitals for cancer – the only ranked in New Jersey with this designation. It is New Jersey's largest and most comprehensive cancer center dedicated to the diagnosis, treatment, management, research, screenings, preventive care, as well as survivorship of patients with all types of cancer.

Each year, more people in the New Jersey/New York metropolitan area turn to John Theurer Cancer Center for cancer care than to any other facility in New Jersey. The 14 specialized divisions feature a team of medical, research, nursing, and support staff with specialized expertise that translates into more advanced, focused care for all patients. John Theurer Cancer Center provides comprehensive multidisciplinary care, state of the art technology, access to clinical trials, compassionate care and medical expertise—all under one roof. Physicians at John Theurer Cancer Center are members of Regional Cancer Care Associates one of the nation’s largest professional hematology/oncology groups. For more information please visit http://www.jtcancercenter.org

Media Contact:
Jon Byington

jtcc@porternovelli.com
212-601-8208